Nasrin Najm-Tehrani

Fellowship Director
Department of Ophthalmology and Vision Sciences

Dr. Najm-Tehrani was trained in medicine in the United Kingdom at The University of Wales, College of Medicine and graduated in 1987. Her ophthalmology training was in Cardiff, Liverpool and Birmingham in the U.K. and she has been a fellow of The Royal College of Surgeons of Edinburgh since 1992 and a fellow of The Royal College of Surgeons of Canada since 2011.

She trained as a fellow in paediatric ophthalmology in The Princess of Wales Hospital in Birmingham, England followed by a second year at The Hospital for Sick Children in Toronto, Canada. During her ophthalmology residency training in the UK she also gained a M.Sc. degree in Health Care Policy and Management.

Tehrani has a special interest in the management of diseases of the anterior segment of the eye, specifically cataracts, glaucoma and uveitis in childhood affecting the newborn through to teen age. Her expertise is in both medical and surgical treatment of challenging and complex cases of paediatric cataracts and glaucoma. She has specialist expertise in management of Retinopathy of Prematurity, a keen interest in introducing telemedicine in the assessment of ROP in the more remote regions of Ontario and is the lead clinician in the ROP service.

Education and experience

• 1987: MB BCh, College of Medicine, University of Wales, Heath Park, Cardiff, United Kingdom
• 1998–2002: Specialist Registrar, West Midlands Specialist Registrar Training Program, University of Birmingham, Birmingham, United Kingdom
• 2002: Clinical Fellowship, Final year of Specialist Registrar training, Paediatric Ophthalmology, Diana Princess of Wales Childrens’ Hospital, Birmingham, United Kingdom
• 2002: M.Sc., Health Care Policy & Management, School of Social Sciences, Health Services Management Centre, University of Birmingham, United Kingdom
• 2003: Clinical Fellowship, Paediatric Ophthalmology & Strabismus, Department of Ophthalmology & Vision Sciences, The Hospital for Sick Children, Toronto, Canada
• 2005–present: Staff Ophthalmologist, Lead Clinician for ROP Program, Ophthalmology, The Hospital for Sick Children, Toronto, Canada

Achievements

• 2019: American Academy of Ophthalmology Achievement Award. Commemorates contributions to the Academy, its scientific and educational programs, and to the advancement of ophthalmology. San Francisco, California, USA.
• 2010: Celebrating Innovations in Health Care 2010, Ministry of Health and Long-term Care, Toronto, Ontario, Canada. (Ministerial Sponsored Health Expo 2010 Achievement Grant)

1. Isaac M, Mireskandari K, Fallaha N, Ospina LH, Javidi E, Chorfi S, Superstein R, Hamel P, Tehrani NN. Long-term outcomes of type 1 Retinopathy of Prematurity following monotherapy with bevacizumab: a Canadian Experience. Can J Ophthalmol. 2023 Dec;58(6):553-558. doi: 10.1016/j.jcjo.2022.07.001. Epub 2022 Aug 6.PMID: 35940211.
2. Zhou, TE, Farinas CP, Kulkarni AV, Dirks P, Brandao LR, Muthusami P, Tehrani NN. More to it than meets the eye: a case report of incomitant esotropia in a child caused by a giant basilar aneurysm. Ann Eye Sci. 2023 Dec; 8:20.
3. Abed A. Baiad, Imaan Z. Kherani, Marko M Popovic, Glen Katsnelson, Rajeev H. Muni, Kamiar Mireskandari, Nasrin N. Tehrani, Tianwei Ellen Zhou, Peter J. Kertes. A meta-analysis of neurodevelopmental outcomes following intravitreal bevacizumab for the treatment of retinopathy of prematurity. Neonatology. 2023 Jul 24:1-12. doi: 10.1159/000531541. Online ahead of print.
4. Promelle V, Mireskandari K, Ali A, Cheung C, Tehrani NN. Outcomes of cataract surgery in children who present with cataract at uveitis diagnosis. J AAPOS. 2023 Jun;27(3):139.e1-139.e5. doi: 10.1016/j.jaapos.2023.02.010. Epub 2023 May 13.PMID: 37187405. Coauthor or Collaborator.
5. Berard R, Ng HY, Human A, Piskin D, Dhalla M, Gottlieb C, Batthish M, Chedeville G, Forest C, Fortin E, Gardiner J, Gerhold K, Jastrzebski A, Lang B, Miettunen P, Morgenstern S, Morin MP, Rosenberg A, Rumsey DG, Solarte CE, Tehrani NN, et al. Canadian Rheumatology Association recommendations for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-associated Uveitis. J Rheumatology. 2022 Oct 15; jrheum.220261. doi: 10.3899/jrheum. 220261. Online ahead of print. Coauthor or Collaborator.